Literature DB >> 26669562

The Neutrophil-to-Lymphocyte Ratio before Repeat Prostate Needle Biopsy for Predicting Prostate Cancer.

Yoko Maeda1, Takashi Kawahara, Yohei Kumano, Mari Ohtaka, Takuya Kondo, Taku Mochizuki, Yusuke Hattori, Jun-Ichi Teranishi, Yasuhide Miyoshi, Yasushi Yumura, Hiroshi Miyamoto, Masahiro Yao, Hiroji Uemura.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26669562     DOI: 10.1159/000442895

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


× No keyword cloud information.
  4 in total

1.  The neutrophil-to-lymphocyte ratio in clinical practice.

Authors:  Ali Gürağaç; Zafer Demirer
Journal:  Can Urol Assoc J       Date:  2016 Mar-Apr       Impact factor: 1.862

2.  Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy.

Authors:  Koichi Uemura; Takashi Kawahara; Daisuke Yamashita; Ryosuke Jikuya; Koichi Abe; Tomoyuki Tatenuma; Yumiko Yokomizo; Koji Izumi; Jun-Ichi Teranishi; Kazuhide Makiyama; Yasushi Yumura; Takeshi Kishida; Koichi Udagawa; Kazuki Kobayashi; Yasuhide Miyoshi; Masahiro Yao; Hiroji Uemura
Journal:  Biomed Res Int       Date:  2017-08-29       Impact factor: 3.411

3.  Prognostic Value of Neutrophil to Lymphocyte Ratio on Pathologic Findings of Transrectal Ultrasonography Guided Biopsy of Prostate.

Authors:  Iraj Khosropanah; Sadeq Rostami; Zhoobin Heidari Bateni; Mojtaba Teimoori; Darya Khosrovpanah
Journal:  Iran J Pathol       Date:  2018-09-12

4.  Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells.

Authors:  Nigel P Murray; Cynthia Fuentealba; Eduardo Reyes; Marco Antonio Lopez; Anibal Salazar; Simona Minzer; Lorena Munoz; Shenda Orrego; Eghon Guzman; Lucas Arzeno
Journal:  Asian Pac J Cancer Prev       Date:  2019-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.